Nicotinamide Renaudin

Nicotinamide, the active ingredient in Nicotinamide Renaudin, is a Vitamin B3 (niacinamide) presented as an injection solution for intramuscular and intravenous use. It is employed to prevent and treat niacin (vitamin B3) deficiency and to support cellular energy metabolism in patients requiring rapid replenishment.

GNH USA supplies Nicotinamide Renaudin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Products are shipped with temperature control where required and supported by technical service teams.

Nicotinamide is used primarily to address niacin deficiency and to support cellular energy pathways. - Niacin (vitamin B3) deficiency: restores normal niacin levels, preventing pellagra and related symptoms. - Cellular energy metabolism support: increases NAD+ and NADP+ precursors, aiding redox reactions and ATP production. - Post‑operative nutritional support: provides rapid vitamin B3 repletion when oral intake is limited. - Skin health maintenance: contributes to keratinocyte function and may improve barrier integrity. - Neurological function support: serves as a cofactor in neuronal NAD+ synthesis, potentially supporting nerve health.

Injection of nicotinamide may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Injection site pain or erythema: mild discomfort or redness at the site of administration. - Nausea or vomiting: transient gastrointestinal upset. - Headache: mild to moderate intensity. - Flushing: brief warmth or redness, less common than with nicotinic acid. - Dizziness: transient sensation of lightheadedness. - Pruritus: mild itching at or away from injection site.

Serious or Rare Side Effects: - Hypersensitivity reactions: rash, pruritus, bronchospasm, or anaphylaxis requiring immediate medical attention. - Severe hepatic dysfunction: elevated transaminases or jaundice in susceptible individuals. - Metabolic